• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Performant Financial Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    5/1/24 5:29:40 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary
    Get the next $PFMT alert in real time by email
    pfmt-20240426
    0001550695FALSE00015506952024-04-262024-04-26

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    FORM 8-K 
     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): April 26, 2024 
     
    Performant Financial Corporation
    (Exact name of registrant as specified in its charter)

    Delaware 001-35628 20-0484934
    (State or other jurisdiction
    of incorporation)
     (Commission
    File Number)
     (IRS Employer
    Identification No.)
    900 South Pine Island Road,
    Plantation, FL 33324
    (Address of principal executive offices) (Zip Code)
    Registrant’s telephone number, including area code: (925)  960-4800

    N/A
    (Former name or former address, if changed since last report.)
     
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
        
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading Symbol(s) Name of exchange on which registered
    Common Stock, par value $.0001 per share
    PFMT
    The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§ 240.12b–2 of this chapter).     

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



    Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
    Chief Executive Officer
    Simeon M. Kohl has served as the Chief Executive Officer of Performant Financial Corporation (the “Company”) since May 2023. Prior to his appointment as the Company’s Chief Executive Officer, Mr. Kohl served as the Company’s President from March 2022 to May 2023, and prior to that, Mr. Kohl served as the Company’s Vice President of Healthcare and Vice President of Sales and Account Management from February 2012 to March 2022. Mr. Kohl has more than 20 years of executive management experience and an extensive background in healthcare cost containment and related services.
    In connection with Kohl’s appointment as the Company’s Chief Executive Officer, on April 26, 2024, the Company entered into an Employment Agreement with Mr. Kohl, effective May 5, 2023 (the “Kohl Employment Agreement”). Under the terms of the Kohl Employment Agreement, Mr. Kohl is entitled to an annual base salary of $345,000 and will have a target annual bonus opportunity of 75% of his annual base salary with the amount earned, if any, based on the achievement of one or more milestones to be established each year by our board of directors, subject to his continuous employment on the last day of the applicable calendar year. In addition, pursuant to the Kohl Employment Agreement, in connection with his appointment as our Chief Executive Officer, Mr. Kohl was granted two (2) restricted stock unit (“RSU”) awards under the Company’s 2012 Stock Incentive Plan. On May 5,2023, Mr. Kohl was granted an RSU award with respect to 366,898 shares of the Company’s common stock with (i) fifty-percent (50%) of the RSUs vesting in four (4) equal installments on each of the first four (4) anniversaries of May 5, 2023, subject to Mr. Kohl’s continued employment on each such date, and (ii) the remaining fifty-percent (50%) of the RSUs vesting subject to performance-based vesting conditions based on predetermined target prices for shares of the Company’s common stock. The Kohl Employment Agreement contains customary confidentiality and intellectual property assignment provisions.
    Concurrently with the execution of the Kohl Employment Agreement, the Company entered into its form of indemnification agreement with Mr. Kohl. Mr. Kohl has no family relationships with any of the Company’s directors or executive officers, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
    Contemporaneously with the execution of the Kohl Employment Agreement, the Company entered into a Change in Control and Severance Agreement with Mr. Kohl (the “Kohl Severance Agreement”). The Kohl Severance Agreement will terminate on April 26, 2027, unless mutually renewed by the parties. Under the Kohl Severance Agreement, in the event Mr. Kohl is either employed at the time of a change in control (as defined in the Kohl Severance Agreement) or his employment terminates as a result of an involuntary termination (as defined in the Kohl Severance Agreement) on or within three (3) months prior to a change in control, subject to his execution of a general release of claims and continued compliance with certain restrictive covenants, all of Mr. Kohl’s equity awards subject to vesting based on performance shall be treated as follows: (i) in the case of a performance-based equity award where performance is measured against the Company’s stock price or similar market-based performance criteria, the performance-based equity award will fully accelerate, (ii) in the case of a performance-based equity award where performance is measured against a business performance metric that is not measured against the Company’s stock price or similar market-based metric, such performance criteria will be deemed satisfied at 100% of target for any unfinished performance period and such performance-based equity award will convert to time based vesting on a ratable basis for the remainder of the original performance period, and (iii) any performance-based equity award for which the performance condition is not deemed satisfied will be forfeited, in each case, effective as of the date of the consummation of the change in control.
    Pursuant to the Kohl Severance Agreement, in the event that Mr. Kohl’s employment terminates as a result of an involuntary termination either on or at any time within twelve months (12) months after a change in control, or within three (3) months prior to a change in control, subject to his execution of a general release of claims and continued compliance with certain restrictive covenants, Mr. Kohl will become entitled to the following severance benefits: (i) a severance payment equal to the sum of one hundred fifty percent (150%) of his then current annual base salary and target bonus, payable in a lump sum on the sixtieth (60th) day following the termination date, (ii) all of Mr. Kohl’s then outstanding equity awards subject to time-base vesting (including any performance-based equity awards that were converted into time-based equity awards upon the change in control) will become fully vested and exercisable, and (iii) a lump sum payment equal to eighteen (18) months of premiums under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, or corresponding provision of state law (“COBRA”) for health insurance coverage for Mr. Kohl and his eligible dependents, at the same level and for the same eligible dependents covered as of his termination date.



    Further pursuant to the Kohl Severance Agreement, in the event Mr. Kohl’s employment terminates as a result of an involuntary termination that occurs more than three (3) months prior to or twelve (12) months after a change in control, subject to his execution of a general release of claims and continued compliance with certain restrictive covenants, Mr. Kohl will become entitled to the following severance benefits: (i) one hundred percent (100%) of his then current annual base salary and target bonus, payable in a lump sum on the sixtieth (60th) day following the termination date, and (ii) a lump sum payment equal to twelve (12) months of premiums under COBRA for health insurance coverage for Mr. Kohl and his eligible dependents, at the same level and for the same eligible dependents covered as of his termination date.
    Chief Financial Officer
    Rohit Ramchandani has served as the Company’s Chief Financial Officer since May 2023. Prior to his appointment as Chief Financial Officer, Mr. Ramchandani served as the Company’s Senior Vice President of Finance and Strategy in addition to a variety of roles at the Company from March 2014 to May 2023. With a background in finance, Mr. Ramchandani has over a decade of financial strategy and operations experience. Mr. Ramchandani holds a Bachelor of Science in Business Administration and a Bachelor of Science in Economics/Mathematics, both from the University of Southern California.
    In connection with Ramchandani’s appointment as the Company’s Chief Financial Officer, on April 26, 2024, the Company entered into an Employment Agreement with Mr. Ramchandani, effective May 5, 2023 (the “Ramchandani Employment Agreement”). Under the terms of the Ramchandani Employment Agreement, Mr. Ramchandani is entitled to an annual base salary of $290,000 and will have a target annual bonus opportunity of 50% of his annual base salary with the amount earned, if any, based on the achievement of one or more milestones to be established each year by our board of directors, subject to his continuous employment on the last day of the applicable calendar year. In addition, pursuant to the Ramchandani Employment Agreement, in connection with his appointment as our Chief Financial Officer, Mr. Ramchandani was granted an RSU award with respect to 216,724 shares of the Company’s common stock with (i) fifty-percent (50%) of the RSUs vesting in four (4) equal installments on each of the first four (4) anniversaries of May 4, 2023, subject to Mr. Ramchandani’s continued employment on each such date, and (ii) the remaining fifty-percent (50%) of the RSUs vesting subject to performance-based vesting conditions based on predetermined target prices for shares of the Company’s common stock. On March 26, 2024, Mr. Ramchandani was granted an RSU award with respect to 52,817 shares of the Company’s common stock with such award vesting in four equal installments on each of the first four anniversaries of the grant date of such award, subject to Mr. Ramchandani’s continued employment on each such date. The Ramchandani Employment Agreement contains customary confidentiality and intellectual property assignment provisions.
    Concurrently with the execution of the Ramchandani Employment Agreement, the Company entered into its form of indemnification agreement with Mr. Ramchandani. Mr. Ramchandani has no family relationships with any of the Company’s directors or executive officers, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
    Contemporaneously with the execution of the Ramchandani Employment Agreement, the Company entered into a Change in Control and Severance Agreement with Mr. Ramchandani (the “Ramchandani Severance Agreement”). The Ramchandani Severance Agreement will terminate on April 26, 2027, unless mutually renewed by the parties. Under the Ramchandani Severance Agreement, in the event Mr. Ramchandani is either employed at the time of a change in control (as defined in the Ramchandani Severance Agreement) or his employment terminates as a result of an involuntary termination (as defined in the Ramchandani Severance Agreement) on or within three (3) months prior to a change in control, subject to his execution of a general release of claims and continued compliance with certain restrictive covenants, all of Mr. Ramchandani’s equity awards subject to vesting based on performance shall be treated as follows: (i) in the case of a performance-based equity award where performance is measured against the Company’s stock price or similar market-based performance criteria, the performance-based equity award will fully accelerate, (ii) in the case of a performance-based equity award where performance is measured against a business performance metric that is not measured against the Company’s stock price or similar market-based metric, such performance criteria will be deemed satisfied at 100% of target for any unfinished performance period and such performance-based equity award will convert to time based vesting on a ratable basis for the remainder of the original performance period, and (iii) any performance-based equity award for which the performance condition is not deemed satisfied will be forfeited, in each case, effective as of the date of the consummation of the change in control.



    Pursuant to the Ramchandani Severance Agreement, in the event that Mr. Ramchandani’s employment terminates as a result of an involuntary termination either on or at any time within twelve months (12) months after a change in control, or within three (3) months prior to a change in control, subject to his execution of a general release of claims and continued compliance with certain restrictive covenants, Mr. Ramchandani will become entitled to the following severance benefits: (i) a severance payment equal to the sum of one hundred percent (100%) of his then current annual base salary and target bonus, payable in a lump sum on the sixtieth (60th) day following the termination date, (ii) all of Mr. Ramchandani’s then outstanding equity awards subject to time-base vesting (including any performance-based equity awards that were converted into time-based equity awards upon the change in control) will become fully vested and exercisable, and (iii) a lump sum payment equal to twelve (12) months of premiums under COBRA for health insurance coverage for Mr. Ramchandani and his eligible dependents, at the same level and for the same eligible dependents covered as of his termination date.
    Further pursuant to the Ramchandani Severance Agreement, in the event Mr. Ramchandani’s employment terminates as a result of an involuntary termination that occurs more than three (3) months prior to or twelve (12) months after a change in control, subject to his execution of a general release of claims and continued compliance with certain restrictive covenants, Mr. Ramchandani will become entitled to the following severance benefits: (i) seventy-five percent (75%) of his then current annual base salary and target bonus, payable in a lump sum on the sixtieth (60th) day following the termination date, and (ii) a lump sum payment equal to nine (9) of premiums under COBRA for health insurance coverage for Mr. Ramchandani and his eligible dependents, at the same level and for the same eligible dependents covered as of his termination date.
    The foregoing descriptions of the Kohl Employment Agreement, Kohl Severance Agreement, Ramchandani Employment Agreement and Ramchandani Severance Agreement are not intended to be complete and are qualified in their entirety by reference to the applicable agreements, which are attached hereto as Exhibits 10.1, 10.2, 10.3 and 10.4 respectively and are incorporated hereby by reference.
    Item 9.01Financial Statements and Exhibits.
    (d) Exhibits
    Exhibit No.
    Description
    10.1#
    Employment Agreement between Performant Financial Corporation and Simeon Kohl, dated April 26, 2024.
    10.2#
    Change in Control and Severance Agreement between Performant Financial Corporation and Simeon Kohl, dated April 26, 2024.
    10.3#
    Employment Agreement between Performant Financial Corporation and Rohit Ramchandani, dated April 26, 2024.
    10.4#
    Change in Control and Severance Agreement between Performant Financial Corporation and Rohit Ramchandani, dated April 26, 2024.
    104
    Cover Page Interactive Data File (embedded within the Inline XBRL document).
    # Indicates management contract or compensatory plan or arrangement.



    SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    Dated: May 1, 2024
     
    PERFORMANT FINANCIAL CORPORATION
    By: /s/Simeon Kohl
     Simeon Kohl
     Chief Executive Officer

    Get the next $PFMT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PFMT

    DatePrice TargetRatingAnalyst
    7/25/2024$8.00Buy
    B. Riley Securities
    12/20/2022$8.00Buy
    Lake Street
    4/11/2022$8.00Buy
    Lake Street
    7/7/2021$10.00Buy
    Craig Hallum
    More analyst ratings

    $PFMT
    SEC Filings

    View All

    Performant Financial Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Performant Healthcare Inc (0001550695) (Filer)

    12/10/24 4:13:29 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    SEC Form 10-Q filed by Performant Financial Corporation

    10-Q - Performant Financial Corp (0001550695) (Filer)

    11/7/24 4:21:13 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Performant Financial Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Performant Financial Corp (0001550695) (Filer)

    11/6/24 4:12:31 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    $PFMT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Im Lisa sold $20,052 worth of shares (6,154 units at $3.26), decreasing direct ownership by 0.43% to 1,410,280 units (SEC Form 4)

    4 - Performant Healthcare Inc (0001550695) (Issuer)

    12/11/24 5:01:13 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer Kohl Simeon converted options into 61,788 shares and covered exercise/tax liability with 15,046 shares, increasing direct ownership by 12% to 424,824 units (SEC Form 4)

    4 - Performant Financial Corp (0001550695) (Issuer)

    8/15/24 8:25:15 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Chief Financial Officer Ramchandani Rohit converted options into 38,687 shares and covered exercise/tax liability with 13,805 shares, increasing direct ownership by 13% to 211,276 units (SEC Form 4)

    4 - Performant Financial Corp (0001550695) (Issuer)

    8/15/24 8:23:05 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    $PFMT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Performant Healthcare, Inc. Ticker Symbol Change to "PHLT"

    Performant Healthcare, Inc. (NASDAQ:PFMT) ("Performant" or the "Company") is pleased to announce that its ticker symbol on the Nasdaq stock exchange will change from "PFMT" to "PHLT" effective as of market open on Wednesday, December 18, 2024. The change reflects Performant's strategic evolution into a pure-play healthcare payment integrity leader, underscoring its commitment to providing innovative solutions that reduce waste and abuse in the healthcare system. The transition to "PHLT" requires no action from shareholders. Performant's common shares will continue to be listed on Nasdaq with no changes to the CUSIP number, GICS, and NAICS codes associated with the Company's common stock

    12/16/24 4:00:00 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Performant Announces Name Change to Performant Healthcare, Inc. – Concludes Strategic Shift to Healthcare

    New Nasdaq Ticker Symbol Will Be PHLT Performant Financial Corporation (NASDAQ:PFMT) today announced it has changed its name to Performant Healthcare, Inc. ("Performant" or the "Company"), and plans to update its ticker symbol to PHLT. The name change and new ticker symbol will not impact the Company's operations, management or structure. Performant, a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, is changing its name to reflect its strategic commitment to becoming a pure-play leader in healthcare payment integrity. "The name Performant Healthcare, Inc. reflects our commitment to delivering world-class payment integrity solution

    12/10/24 5:00:00 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Performant to Participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference

    Performant Financial Corporation (NASDAQ:PFMT) (the "Company"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that it will participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference, taking place in Boca Raton on Tuesday, December 3rd. Simeon Kohl, CEO, will present and meet with investors to discuss key updates, including the recent New York State Medicaid RAC award, progress on efficiency initiatives aimed at margin improvement, successful commercial implementations and a robust pipeline, and upcoming government opportunities. We're excited to share these developments as we continue dr

    11/26/24 4:05:00 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    $PFMT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities initiated coverage on Performant Financial with a new price target

    B. Riley Securities initiated coverage of Performant Financial with a rating of Buy and set a new price target of $8.00

    7/25/24 8:25:58 AM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Lake Street resumed coverage on Performant Financial with a new price target

    Lake Street resumed coverage of Performant Financial with a rating of Buy and set a new price target of $8.00

    12/20/22 9:21:46 AM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Lake Street initiated coverage on Performant Financial with a new price target

    Lake Street initiated coverage of Performant Financial with a rating of Buy and set a new price target of $8.00

    4/11/22 9:19:13 AM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    $PFMT
    Leadership Updates

    Live Leadership Updates

    View All

    Performant Financial Corporation Announces the Appointment of Dr. Shantanu Agrawal to Its Board of Directors

    Performant Financial Corporation (NASDAQ:PFMT) (Performant), primarily operating as Performant Healthcare Solutions, a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, is proud to announce the appointment of Dr. Shantanu Agrawal, M.D. to its Board of Directors. Dr. Agrawal brings a wealth of expertise and experience in healthcare policy and payment integrity. As Chief Health Officer at Elevance Health (NYSE:ELV), Dr. Agrawal oversees the whole health strategy, including medical policy and clinical quality, as well as the community health strategy and Elevance Health Foundation. Prior to Elevance Health, Dr. Agrawal held numerous execut

    3/6/24 4:30:00 PM ET
    $ELV
    $PFMT
    Medical Specialities
    Health Care
    Other Consumer Services
    Consumer Discretionary

    $PFMT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Performant Financial Corporation

    SC 13G/A - Performant Financial Corp (0001550695) (Subject)

    11/15/24 7:03:26 AM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Performant Financial Corporation

    SC 13G/A - Performant Financial Corp (0001550695) (Subject)

    11/14/24 4:41:31 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13G filed by Performant Financial Corporation

    SC 13G - Performant Financial Corp (0001550695) (Subject)

    4/18/24 6:08:28 AM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    $PFMT
    Financials

    Live finance-specific insights

    View All

    Performant Financial Corporation Announces Financial Results for Third Quarter 2024

    Performant Financial Corporation (NASDAQ:PFMT), a leading provider of healthcare payment integrity services, today reported the following financial results for its third quarter ended September 30, 2024: Third Quarter Financial Highlights Healthcare revenues of $30.3 million, compared to $28.5 million in the prior year period, an increase of approximately 6%. Total revenues of $31.5 million, compared to total revenues of $30.0 million in the prior year period. Net loss of $2.4 million, or $(0.03) per diluted share, compared to net loss of $0.6 million, or $(0.01) per diluted share, in the prior year period. Adjusted EBITDA of $1.9 million, compared to $1.8 million in the prior year

    11/6/24 4:00:00 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Performant Financial Corporation to Report Third Quarter 2024 Earnings on November 6, 2024

    Performant Financial Corporation (NASDAQ:PFMT) (the Company), primarily operating under subsidiary Performant Healthcare Solutions, a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that the company will report its third quarter 2024 results after the market closes Wednesday November 6, 2024. The Company will also hold a conference call to discuss results at 5:00 pm (Eastern Time) that day. To join the conference call: Dial in 800-717-1738 or 646-307-1865, or Live webcast through company's website here Replay can be found approximately three hours after the call on the company website under the Events & Presentations

    10/23/24 10:30:00 AM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary

    Performant Financial Corporation Announces Financial Results for Second Quarter 2024

    Performant Financial Corporation (NASDAQ:PFMT), a leading provider of healthcare payment integrity services, today reported the following financial results for its second quarter ended June 30, 2024: Second Quarter Financial Highlights Healthcare revenues of $27.9 million, compared to $23.9 million in the prior year period, an increase of approximately 17%. Total revenues of $29.4 million, compared to total revenues of $25.5 million in the prior year period. Net loss of $3.0 million, or $(0.04) per diluted share, compared to net loss of $4.0 million, or $(0.05) per diluted share, in the prior year period. Adjusted EBITDA of $0.5 million, compared to $(1.3) million in the prior

    8/7/24 4:00:00 PM ET
    $PFMT
    Other Consumer Services
    Consumer Discretionary